Beam Chemotherapy For Hodgkin's Lymphoma

Beam Chemotherapy For Hodgkin’s Lymphoma

Posted on

Beam Chemotherapy For Hodgkin's Lymphoma

BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma.. The minimum follow-up duration of all patients is 6 months.
Outpatient Administration of High Dose BEAM Chemotherapy As. patients with Hodgkin's or non-Hodgkin's lymphoma that persists or recurs following standard .
Lymphoma Hodgkin's Disease, Drug: Melphalan Drug: Ara-C Drug: VP-16 Drug:. Study of Rituxan in Patient Receiving BEAM Chemotherapy and Autologous .
lymphoma or Hodgkin's lymphoma who require additional therapy following standard chemotherapy. The aim is to either cure your disease, or lengthen.
High-dose BEAM chemotherapy with autologous peripheral blood. for unselected patients with primary refractory or relapsed Hodgkin's disease. . relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.